SCHEMBL7729271

SCHEMBL7729271

CCCC(NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(C)C)C(=O)C(=O)NCC(=O)O

nearest known ligand 0.40

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ MALT1 Q9UDY8 1/20 0.40
▸ CMA1 P23946 3/20 0.40
▸ XIAP P98170 1/20 0.39
▸ MLX Q9UH92 1/20 0.39
▸ ELANE P08246 4/20 0.39
▸ CAPN1 P07384 2/20 0.39
▸ KEAP1 Q14145 2/20 0.39
▸ CALCRL Q16602 2/20 0.38
▸ CASP3 P42574 1/20 0.38
▸ CASP2 P42575 1/20 0.38
▸ F2 P00734 2/20 0.38
▸ EPHA2 P29317 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7735915 0.97 MALT1 (0.42) MALT1CMA1XIAPMLXELANE
SCHEMBL7736364 0.95 MALT1 (0.40) MALT1CMA1XIAPMLXELANE
SCHEMBL7736683 0.95 CASP3 (0.41) MALT1CMA1ELANEKEAP1CALCRL
SCHEMBL7736050 0.95 CASP3 (0.41) MALT1CMA1ELANEKEAP1CALCRL
SCHEMBL7736353 0.95 CASP3 (0.41) MALT1CMA1ELANEKEAP1CALCRL
SCHEMBL7736573 0.95 CAPN1 (0.40) MALT1CAPN1KEAP1CALCRLCASP3
SCHEMBL7728310 0.95 CASP3 (0.43) MALT1CMA1ELANEKEAP1CALCRL
SCHEMBL7729363 0.93 CALCRL (0.44) MALT1CMA1ELANEKEAP1CALCRL
SCHEMBL7736915 0.93 KEAP1 (0.42) MALT1CMA1ELANECAPN1KEAP1
SCHEMBL7736380 0.93 ITGB3 (0.40) MALT1CMA1ELANEKEAP1CALCRL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6800434-B2 Peptides as NS3-serine protease inhibitors of hepatitis C virus SCHERING CORPORATION 2004-10-05 — — US disclosed
US-6800434-B2 Peptides as NS3-serine protease inhibitors of hepatitis C virus SCHERING CORPORATION 2004-10-05 — — US disclosed
Send feedback